chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On 09/18/2022 around 8:00PM I had fever, loss of taste/smell, cough, runny nose, shortness of breath, and fatigue. On 09/19/2022 since I work at the hospital, I went to the health department to check for COVID-19 and, the result was positive. I stayed home for about 7 days. I didn't see a doctor. I treated symptoms at home as like a cold. I still have a lingering loss of taste and smell but all the other symptoms are gone.
1/2 I woke up and I threw up and I had body aches and lethargy and I slept all day for like 12 hours which is not normal. My arm was sore but nothing out of the ordinary. Daily asprin after I got covid Dec 8th and I took Tylenol on the 2nd to be a little more comfortable  I have been having a normal low risk pregnancy but my Dr made me high risk since I had COVID, Due Date: May 30th
arm soreness; muscle aches in the body; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm soreness) and MYALGIA (muscle aches in the body) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B21-2A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, the patient experienced PAIN IN EXTREMITY (arm soreness) and MYALGIA (muscle aches in the body). At the time of the report, PAIN IN EXTREMITY (arm soreness) and MYALGIA (muscle aches in the body) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information included Aspirin.
18 year old male presented for vaccine follow-up. Pt did not have any records and proceeded with catch-up vaccination for school entry. Parent accompanied the pt. Prior to vaccine administration, Pt was feeling nervous but was comfortable to proceed.  Pt had a vasovagal response after receiving all intramuscular and intradermal injections. Pt was diaphoretic, and was laid down. Initial BP taken of 84/60, Pt was responsive but eyes were closed. Pt opened eyes given an ice pack to neck and juice. Responded well. Pt was laid down for 10 minutes. After sitting, retake BP 110/75. Pt states that he was feeling better and wanted to continue with remaining subcutaneous injections. Pt left clinic stable. Pt was instructed if any other reactions occur to visit emergency care. Pt will follow up in 2 days at the clinic for TB test review and for a general nurse visit to ensure no further reactions occurred to vaccines.
felt a little light headed; This is a spontaneous report from a non-contactable nurse (patient) via Regulatory Authority. . An adult female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 06Jan2021 as dose 1, single for COVID-19 immunisation. The patient reported that she has thyroid disease, and she was taking levothyroxine. She was also taking hydroxychloroquine (PLAQUENIL) because she has a connected tissue disease. The patient also reported that she is at the age of menopause. On 06Jan2021, the patient received first dose of BNT162B2. She felt fine, she only felt a little light headed (on an unspecified date in Jan2021), nothing significant. The outcome of the event was unknown.  No follow-up attempts are possible. Information about lot/batch number could not be obtained. No further information is expected.
Redness, itching, pain, spot sore/hot to touch -(antibiotic course, BENADRYL) headache - redness at injection site as large as a baseball)
Headache, generalized muscle aches/pain, hot flashes, 7/10 left shoulder pain (injection site) and left are twitching.
Information has been received from a nurse referring to multiple unspecified patients of unknown age and gender. Information about concurrent conditions, medical history and concomitant medication was not provided. On an unknown date the patients received either VARIVAX (Merck) (lot # K007781, expire date 28-MAY-2016; lot# K011800, expire date 21-AUG-2016; L009203, expire date 17-MAR-2017, dose, dose# and route not provided) or PROQUAD (Merck) (lot# K011967, 21-FEB-2016; L009209, 17-SEP-2016, dose, dose# and route not provided) that were improperly stored. No adverse effects reported. The outcome of the event was not reported. Additional information has been requested.
Woke up with extreme leg aches and low grade fever, also noticed that my arm was really sore, swollen, red and hot to the touch. Took Tylenol and Benadryl.  This continued from Wednesday-Saturday.  On Sunday, I began feeling normal again, except that my arm is still sore, red, swollen, bruised, and hot to the touch.
A lot of shooting pains in my back near my shoulder blade, it almost feels like how shin splints feels but it's in my back; Body aches; Chills; Couldn't sleep I kept tossing and turning, I couldn't get comfortable; It's very uncomfortable, I could not sleep last night, I'm just a little worried; Couldn't sleep I kept tossing and turning, I couldn't get comfortable; It's very uncomfortable, I could not sleep last night, I'm just a little worried; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 36 year-old female patient received bnt162b2 (BNT162B2), administration date 14Aug2021 (Batch/Lot number: unknown) at the age of 36 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose:1, LOT: EA7485), administration date: 24Jul2021, when the patient was 36 years old, for Covid-19 immunisation. The following information was reported: BACK PAIN (non-serious) with onset Aug2021, outcome "not recovered", described as "A lot of shooting pains in my back near my shoulder blade, it almost feels like how shin splints feels but it's in my back"; PAIN (non-serious) with onset Aug2021, outcome "not recovered", described as "Body aches"; CHILLS (non-serious) with onset Aug2021, outcome "unknown", described as "Chills"; INSOMNIA (non-serious), DISCOMFORT (non-serious) all with onset Aug2021, outcome "unknown" and all described as "Couldn't sleep I kept tossing and turning, I couldn't get comfortable; It's very uncomfortable, I could not sleep last night, I'm just a little worried". Therapeutic measures were taken as a result of back pain, pain.  Additional information: Patient had no history. Consumer stated, calling to report a side-effect that having from the vaccine (Pfizer COVID 19 Vaccine), had received second dose yesterday and patient experiencing a side-effect. Patient did take Tylenol last night also before bed and it just didn't seem to help the pain. Patient also experienced the other symptoms the body aches, chills, all that other stuff but the shooting pains was something that wasn't prepared for. LOT for Tylenol: SMC133. NDC: 50580-414-04, UPC: 0045055024 and Dosage: 325 mg, patient took 2, it's a pack of 2.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
error made: no diluent used Received concentrated dose, approx 28mg given instead of 10 mcg outcome - no fever. & soreness at injection site within 24 H. Otherwise   no           symptoms.
5Oct94 had sore arm; heart beating real fast; 6Oct94 congestion in throat;
Pt stated itching all over face, stomach, back, arms, legs and hands with rash. Pt has dry skin before. No new soap, no new food. Instructed to go to pharmacy for over the counter lotion for dry skin.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. On 20-DEC-2013 the patient received first dose of M-M-R II (lot # 671686/1874AA exp. date:30-NOV-2013, dose, strength, site and route of administration not reported) which has expired for vaccination. No adverse event reported. This is one of two reports from the same reporter. Linked case MARRS # 1401USA004043. Additional information is not expected.
Patient hospitalized for Acute Respiratory Failure D/T covid-19.  Requiring O2.
Mother states child has had vomiting x 12 hours, is unable to keep down liquids or food, no fever noted, no rash noted. Phone call to pt on 3/31/00, mother state child is better, no nausea or vomting since last night. Instructed her to see MD if problem occurs again.
Softball sized hot, pruritic, erythematous rash has developed around injection site.
Severe tenosynovitis in ipsilateral wrist of injection occuring ~12 hours after injection sudden onset when sleeping.
12 Oct 15: Patient complained of left side chest pain, 7/10, which had been gradually increasing since 08 Oct 15.  Pain was worse with deep breaths. Treating physician wrote, "small left-sided pleural effusion with otherwise clear lungs." Diagnosis: Acute pleural effusion. Treated with NSAIDS by mouth for pain. 21 Oct 15: Symptoms resolved.
Patient was given one dose of the Pfizer vaccine today but we did not realize that he had already received a J&J vaccine in April 2021 in his home country. Patient does not currently report any side effects.
Information has been received form a licensed practical nurse concerning a "very healthy" 67 year old female pt with no known allergies and no significant past medical hx who on 07JUL203 was vaccinated with dose of pneumococcal vaccine 23 polyvalent. There was no concomitant medication. Subsequently in July 2003, the pt developed weakness, malaise and decreased alertness. Unspecified medical attention was sought, but no treatment was required. As of 29JUL2003, the weakness, malaise and decreased alertness had not abated. A product quality complaint was not involved. The reporter noted that the pt's husband also had similar experience following vaccination with dose of pneumococcal vaccine 23 polyvalent.. Additional information has been requested.
This spontaneous report as received from another health professional refers to a patient of unknown age and gender. No medical history or concurrent conditions were reported. It was reported that on 03-SEP-2013, GARDASIL went out of range as it was exposed to 31.2 F for 6 hours. On 26-SEP-2013, the patient was administered with this improperly stored GARDASIL (route of administration unknown) for an unknown indication. Lot number was reported as H021861 with an expiration date of 09-OCT-2015. No adverse effects were reported. No further information was provided. This is one of 16 reports from the same reporter. Additional information has been requested.
Initial report received from a health care professional (nurse) on 25 May 2010: This patient was vaccinated with MENVEO (batch no: 100001), (dose: unknown) intramuscularly on 24 May 2010. The patient was administered only the diluent portion of MENVEO. No adverse event had occurred. Follow up report received from a physician on 16 Jun 2010: The patient was not vaccinated again, no action was taken. The patient was on concomitant drug ORTHO-TRI-CYLEN for contraception since an unknown date.
could not mover her arm, cannot lift arm; no strength to support arm; inability to sleep; entire top of her arm hurts to the touch; Shooting pain from shoulder into her back; Shooting pain from shoulder into her back, up her neck; Tiny bruise; Shooting pain from shoulder; Nausea; Fatigue; Shooting pain from shoulder into her back, up her neck and into the left side of her head; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (could not mover her arm, cannot lift arm), MUSCULAR WEAKNESS (no strength to support arm), INSOMNIA (inability to sleep), PARAESTHESIA (entire top of her arm hurts to the touch) and BACK PAIN (Shooting pain from shoulder into her back) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Heart attack. Concurrent medical conditions included Hypertension and Type 2 diabetes mellitus.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (could not mover her arm, cannot lift arm), MUSCULAR WEAKNESS (no strength to support arm), INSOMNIA (inability to sleep), PARAESTHESIA (entire top of her arm hurts to the touch), BACK PAIN (Shooting pain from shoulder into her back), NECK PAIN (Shooting pain from shoulder into her back, up her neck), CONTUSION (Tiny bruise), ARTHRALGIA (Shooting pain from shoulder), NAUSEA (Nausea), FATIGUE (Fatigue) and HEADACHE (Shooting pain from shoulder into her back, up her neck and into the left side of her head). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency; ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL, SALICYLAMIDE (EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;PARACETAMOL;SALICYLAMIDE]) for Adverse event, at an unspecified dose and frequency; Physical therapy (applied a sling) for Muscular weakness; Physical therapy (heat and ice) for Back pain; Physical therapy (heat and ice) for Neck pain; Physical therapy (heat and ice) for Contusion; Physical therapy (heat and ice) for Arthralgia and Physical therapy (heat and ice) for Headache. At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (could not mover her arm, cannot lift arm), MUSCULAR WEAKNESS (no strength to support arm), INSOMNIA (inability to sleep), PARAESTHESIA (entire top of her arm hurts to the touch), BACK PAIN (Shooting pain from shoulder into her back), NECK PAIN (Shooting pain from shoulder into her back, up her neck), ARTHRALGIA (Shooting pain from shoulder), NAUSEA (Nausea), FATIGUE (Fatigue) and HEADACHE (Shooting pain from shoulder into her back, up her neck and into the left side of her head) had not resolved and CONTUSION (Tiny bruise) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitantly, patient was taking unspecified blood thinner and hypertension medications.
Hard to breath, right chest, raised, swollen, rock hard injection site (left arm), dizziness, fainting, all over body ache (feels like I?m being stabbed all over), severe migraines, can?t walk or stand or drive longer than 10 minutes.
Felt so light headed, dizziness; she wasn't able to remember things; A spontaneous report was received from an 59-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced Dizziness (Felt so light headed, dizziness)  and Memory impairment (she wasn't able to remember things).  The patient's medical history was not provided. Relevant concomitant medications include Rosuvastatin and vitamins. On 19 Jan 2021, 5 days prior to the onset of the events, the patient received first of two planned doses of mRNA-1273 (lot/batch: 016b21a) intramuscularly in the right arm for prophylaxis of COVID-19 infection.   On 30 MAR 2021 8:40 am,  the patient  experienced Dizziness and Memory impairment.  Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not reported..  The outcome of events Dizziness and Memory impairment was not reported.
After first COVID-19 vaccination, patient experienced fullness in knuckles to the point where he could not make a tight fist.
Immediate intense deep itching at injection site. Itchy throat and mild swelling of mouth.  Treated with Benadryl
This spontaneous case reported by a consumer, describes the occurrence of shortened coagulation time (blood hasn't clotted this quickly before) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 053E21A) for COVID-19 immunization. No medical history reported. On Aug 26, 2021 at 10:25 am, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Aug 26, 2021, patient experienced shortened coagulation time (blood hasn't clotted this quickly before). At the time of the report, shortened coagulation time (blood hasn't clotted this quickly before) outcome: unknown/not provided. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. Concomitant medications and treatment information not reported. Patient reported she never experienced a blood clot so quickly before.
No known adverse event--- reporting vaccine error.    Pfizer vaccine was administered to patient after improper storage. The vaccine was kept in the freezer longer than 2 weeks and was no longer viable at the time of administration.  Pharmacy will re-administer the vaccine.
2.5cm fluid filled vesicle at injection site on left deltoid with erythema and swelling extending to elbow.
This spontaneous report as received from a nurse refers to an unspecified number of patient of unknown demographics. No concurrent conditions or medical history were provided. On an unknown date, those patients were vaccinated with doses of (Oka/Merck) VARIVAX injection (strength, dose, route od administration, indication, lot # and expiry date unspecified), that were improperly stored. No concomitant medications were reported. No adverse effects were reported.  Additional information has been requested.
Soreness & pain in left upper arm.   Attributed it to a side-effect at first, but it has now been a month and it has not gone away.
Initial and follow-up information has been received from a registered nurse concerning a 38-months old male pt w/NKDA and no past medical history who 03/31/1999 was vaccinated at a clinic with varicella virus vaccine live. Concomitant therapy at the clinic on 03/31/1999 included a dose of MMR, IPOL and hib conjugate vaccine (manufacturer unknown). There was no concomitant medicines or illnesses. On 06/11/01, the pt presented to the physician's office with a chicken pox rash (a few pox on arms and legs, one or two on face, and a moderate amount on trunk). It was noted that the pt was febrile. The pt subsequently recovered from the chicken pox rash. No further information is available.
Pt reports sunburn last week during trip. But this redness, rash initially around neck, clavicle area. Burning, itching, has spread down to chest and now rib cage symetrically. yesterday, became blistered after working outdoors in the afternoon.
Pain and muscle stiffness at injection site; fever; chills; tremors; body ache; fatigue; rash across top front of thighs the first night; diffuse headache (all-over surface headache, rather than sharp or throbbing interior headache); inflammation of node in right armpit. First 24 hours were the worst for body aches, fever, chills. Subsequently subsided gradually. But headache and fatigue/weakness lasted >48 hours.
nausea; stomach pain; sore arm; stiff arm; runny nose; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea), ABDOMINAL PAIN UPPER (stomach pain), PAIN IN EXTREMITY (sore arm), MUSCULOSKELETAL STIFFNESS (stiff arm) and RHINORRHOEA (runny nose) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 immunization.     The patient's past medical history included No adverse event (No medical history reported). Concomitant products included PROBIOTICS NOS and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced NAUSEA (nausea), ABDOMINAL PAIN UPPER (stomach pain), PAIN IN EXTREMITY (sore arm), MUSCULOSKELETAL STIFFNESS (stiff arm) and RHINORRHOEA (runny nose). At the time of the report, NAUSEA (nausea), ABDOMINAL PAIN UPPER (stomach pain), PAIN IN EXTREMITY (sore arm), MUSCULOSKELETAL STIFFNESS (stiff arm) and RHINORRHOEA (runny nose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment was reported.
Patient hot and flushed in the head, face, neck, and back area.  It was disappears after 10 minutes. The patient was given Benadryl 25mg as a precaution.
patient received only a half of the dose of Bexsero due to a syringe leak; syringe leak; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incomplete dose administered in a 17-year-old female patient who received Men B NVS (Bexsero) (batch number J52PN, expiry date 31-MAR-2024) for prophylaxis.   On 22-JUN-2023, the patient received Bexsero. On 22-JUN-2023, an unknown time after receiving Bexsero, the patient experienced incomplete dose administered (Verbatim: patient received only a half of the dose of Bexsero due to a syringe leak) and syringe leak (Verbatim: syringe leak). The outcome of the incomplete dose administered and syringe leak were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 22-Jun-2023 The Vaccine Administration Facility was the same as Primary Reporter. The reporter consented to follow-up. Earlier on the day of reporting, a patient received only a half of the dose of Bexsero due to a syringe leak, which led to incomplete dose administered and syringe leak.
veins leaking blood under the skin on mt left and right arms the come and go / blood in urine for 3 hours with no stomach or back pains the leaking veins started 2 days after the shot on April 12th continuing to today on different parts of my body / the blood in urine occurred on June 11th
72 hours after her second Shingrix vaccination, patient had to access the ER for hives and throat swelling where she received epinephrine, Benadryl and "something else"  The pharmacy used Shingrix Lot 52R7X, with adjuvant Lot 92NA4, on 9.13.2019. Patient reported incident to pharmacy today, 9.19.2019.
Woke up with stiff neck; Hip hurts; Depression; It is bad; Has no energy; Gotten sick from the shot/Is so sick; Very tired; Headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Woke up with stiff neck), ARTHRALGIA (Hip hurts), DEPRESSION (Depression), FEELING ABNORMAL (It is bad) and ASTHENIA (Has no energy) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020F21A and 006D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Arteriovenous malformations (flowing vein" or swollen vein in the skull by the eye) in 2009. Concomitant products included WARFARIN and WARFARIN for Deep vein thrombosis, TOPIRAMATE for Headache, VENLAFAXINE and CITALOPRAM for an unknown indication.   On 29-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (Woke up with stiff neck), ARTHRALGIA (Hip hurts), DEPRESSION (Depression), FEELING ABNORMAL (It is bad), ASTHENIA (Has no energy), MALAISE (Gotten sick from the shot/Is so sick), FATIGUE (Very tired), HEADACHE (Headache) and CHILLS (Chills). At the time of the report, MUSCULOSKELETAL STIFFNESS (Woke up with stiff neck), ARTHRALGIA (Hip hurts), DEPRESSION (Depression), FEELING ABNORMAL (It is bad), ASTHENIA (Has no energy), MALAISE (Gotten sick from the shot/Is so sick), FATIGUE (Very tired), HEADACHE (Headache) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Aug-2021, SARS-CoV-2 test: positive (Positive) COVID-19 virus test was positive.         The treatment information was not provided.  Patient had swollen vein  behind the neck in 2009 and she still wears a neck brace that "pumps up and stretches the skull.   This case was linked to MOD-2021-299861 (Patient Link).